Biblio
Autologous stem cell transfusions on multiple days in patients with multiple myeloma - does it matter?. Hematol Oncol. 2019.
. . .
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers (Basel). 2023;15(10).
. Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia. PLoS One. 2014;9(9):e107587.
Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity After Supportive Stem Cell Boost in Multiple Myeloma. Acta Haematol. 2024.
. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021;22(2):223-234.
. Risk stratification systems for allogeneic haematopoietic stem-cell transplantation. Lancet Haematol. 2021;8(3):e166-e167.
. .